These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1053938)

  • 1. Meningeal leukemia after blastic transformation of chronic myeloid leukemia.
    Atkinson K; Kay HE; Lawler SD; Wells DG; McElwain TJ
    Cancer; 1975 Feb; 35(2):529-33. PubMed ID: 1053938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningeal leukemia in the blastic phase of chronic granulocytic leukemia.
    Schwartz JH; Canellos GP; Young RC; DeVita VT
    Am J Med; 1975 Dec; 59(6):819-28. PubMed ID: 1059328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic response of blastic crisis of chronic myeloid leukemia (CML).
    Casirola G; Ippoliti G; Invernizzi R; Marini G
    Acta Haematol; 1978; 59(5):317-8. PubMed ID: 417555
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningeal leukemia following lymphoid blast crisis in chronic myeloid leukemia: therapeutic implications.
    Cazzola M; Nalli G; Brusamolino E; Daccò M; Ghizzi A; Molinari E; Tagliabue A
    Tumori; 1982 Jun; 68(3):257-63. PubMed ID: 6958115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience on the treatment of chronic myelocytic leukaemia (CML) in blastic crisis.
    Mandelli F; Amadori S; Alimena G; Annino L; Nardelli S; Papa G
    Scand J Haematol; 1977 Nov; 19(5):496-502. PubMed ID: 271352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhood.
    Meyer RJ; Cuttner J
    Cancer; 1978 Jul; 42(1):305-10. PubMed ID: 276416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningeal leukemia after blastic transformation of chronic myeloid leukemia.
    Pai VR; Shetty PA
    Indian J Cancer; 1984; 20(6):283-5. PubMed ID: 6590464
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blastic crisis in chronic granulocytic leukemia: experience in 39 patients.
    Vallejos CS; Trujillo JM; Cork A; Bodey GP; McCredie KB; Freireich EJ
    Cancer; 1974 Nov; 34(5):1806-12. PubMed ID: 4529662
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of the blastic crisis of chronic myelogenous leukemia with the combination of vindesine and prednisolone, and cytosine arabinoside.
    Uzuka Y; Saito Y
    Tohoku J Exp Med; 1983 Apr; 139(4):419-20. PubMed ID: 6575487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningeal leukaemia in the blastic phase of chronic granulocytic leukaemia.
    Van Bever H; Benoit Y; Delbeke MJ; Orye E
    Eur J Pediatr; 1985 Nov; 144(4):417-8. PubMed ID: 3865773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis and clinical patterns of blastic crisis of chronic myeloid leukemia.
    Boggs DR
    Semin Oncol; 1976 Sep; 3(3):289-96. PubMed ID: 1068530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blastic transformation in chronic myelogenous leukemia: experience with 50 patients.
    Marks SM; McCaffrey R; Rosenthal DS; Moloney WC
    Med Pediatr Oncol; 1978; 4(2):159-67. PubMed ID: 275533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of the blastic phase of chronic myeloid leukaemia. A question to solve.
    Cerny V; Koza I; Halko J; Bohunicky L; Krizan Z; Poliakova L; Petrek C
    Haematologica; 1972 Apr; 57(11):753-9. PubMed ID: 4200310
    [No Abstract]   [Full Text] [Related]  

  • 16. Dibromomannitol (NSC-94100): a clinical study of previously treated patients with refractory chronic myelocytic leukemia and blastic transformation.
    Levin WC; Mims CH; Haut A
    Cancer Chemother Rep; 1974; 58(2):223-8. PubMed ID: 4598242
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolated central nervous system granulocytic sarcoma and meningeal myeloid leukemia: successful treatment without radiotherapy.
    Stepensky P; Revel-Vilk S; Yehuda-Gafni O; Mali B; Resnick IB; Weintraub M
    Isr Med Assoc J; 2009 Sep; 11(9):569-70. PubMed ID: 19960855
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocular complications following blast transformation in chronic myelogenous leukemia.
    Hendrick AM; Rogers JS; Guliner RJ
    Am J Hematol; 1979; 7(4):389-94. PubMed ID: 296653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Philadelphia chromosome-positive chronic myeloid leukemia with washing out of Ph'-negative lymphoid blasts and with meningiosis: atypical blast crisis or a 2d leukemia?].
    Merlin D; Auf der Maur P; Kappeler R
    Schweiz Med Wochenschr; 1984 Mar; 114(9):303-8. PubMed ID: 6584970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelogenous leukemia presenting in blastic crisis.
    Bornstein RS; Nesbit M; Kennedy BJ
    Cancer; 1972 Oct; 30(4):939-41. PubMed ID: 4507469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.